Effect of antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF

Genes and Immunity

Volumn 5, Issue 7, 2004, Pages 553-561

  Sedegah, M ^a   Charoenvit, Y ^a   Aguiar, J ^a   Sacci, J ^a,e   Hedstrom, R ^a,f   Kumar, S ^a,g   Belmonte, A ^a   Lanar, D E ^b   Jones, T R ^a   Abot, E ^a   Druilhe, P ^c   Corradin, G ^d   Epstein, J E ^a   Richie, T L ^a   Carucci, D J ^a   Hoffman, S L ^a,h  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f DynPort Vaccine Company LLC   (United States)

^g CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^h SANARIA INC   (United States)

Author keywords

Malaria; T lymphocytes; Vaccination

Indexed keywords

ANTIGEN; CELL PROTEIN; CIRCUMSPOROZOITE PROTEIN; DNA VACCINE; EXP1 PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIVER STAGE ANTIGEN 1; LIVER STAGE ANTIGEN 3; MALARIA VACCINE; PARASITE ANTIBODY; PLASMID DNA; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN; SPOROZOITE SURFACE PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC VARIABILITY; GOOD MANUFACTURING PRACTICE; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOGENICITY; LYMPHOCYTE DEPLETION; MALARIA FALCIPARUM; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STRAIN DIFFERENCE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ANIMALS; ANTIBODIES, PROTOZOAN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; PLASMODIUM FALCIPARUM; PROTEIN ENGINEERING; PROTOZOAN VACCINES; T-LYMPHOCYTES; VACCINES, DNA;

MURINAE; PLASMODIUM FALCIPARUM;

EID: 8844245611     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364125     Document Type: Article

References (32)

1. Hoffman SL, Franke ED, Hollingdale MR, Druilhe P. Attacking the infected hepatocyte. In: Hoffman SL (ed). Malaria Vaccine Development: A Multi-Immune Response Approach. ASM Press: Washington, DC, 1996, pp 35-75.
2. Sedegah M, Hedstrom R, Hobart P, Hoffman SL. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 1994; 91: 9866-9870.
3. Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL. Circumventing genetic restriction of protection against malaria with multi-gene DNA immunization: CD8+ T cell, interferon-gamma, and nitric oxide dependent immunity. J Exp Med 1996; 183: 1739-1746.
4. Hedstrom RC, Doolan DL, Wang R et al. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. Int J Mol Med 1998; 2 29-38.
5. Aguiar JC, Hedstrom RC, Rogers WO et al. Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 2001; 20: 275-280.
6. Jones TR, Narum DL, Gozalo AS et al. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 prime-protein boost immunization regimen. J Infect Dis 2001; 183: 303-312.
7. Jones TR, Gramzinski RA, Aguiar JC et al. Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture. Vaccine 2002; 20: 1675-1680.
8. Rogers WO, Baird JK, Kumar A et al. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect Immun 2001; 69: 5565-5572.
9. Wang R, Doolan DL, Charoenvit Y et al. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect Immun 1998; 66: 4193-4202.
10. Wang R, Doolan DL, Le TP et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998; 282: 476-480.
11. Le TP, Coonan KM, Hedstrom RC et al. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 2000; 18: 1893-1901.
12. Wang R, Epstein J, Baraceros FM et al. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci USA 2001; 98: 10817-10822.
13. Weiss WR, Ishii KJ, Hedstrom RC et al. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol 1998; 161: 2325-2332.
14. Sedegah M, Weiss W, Sacci Jr JB et al. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF encoding plasmid DNA and boosting with antigen expressing recombinant poxvirus. J Immunol 2000; 164: 5905-5912.
15. Kumar S, Epstein JE, Richie TL et al. A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol 2002; 18: 129-135.
16. Hoffman SL, Doolan DL. Malaria vaccines-targeting infected hepatocytes. Nat Med 2000; 6: 1218-1219.
17. Malik A, Egan JE, Houghten RA, Sadoff JC, Hoffman SL. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc Natl Acad Sci USA 1991; 88: 3300-3304.
18. + cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J Immunol 1992; 149: 966-971.
19. Weiss WR, Berzovsky JA, Houghten RA, Sedegah M, Hollingdale M, Hoffman SL. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J Immunol 1992; 149: 2103-2109.
20. Doolan DL, Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol 2000; 165: 1453-1462.
21. Perlaza BL, Sauzet JP, Balde AT et al. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice. Eur J Immunol 2001; 31: 2200-2209.
22. Meraldi V, Nebie I, Moret R et al. Recognition of synthetic polypeptides corresponding to the N- and C-terminal fragments of Plasmodium falciparum Exp-1 by T-cells and plasma from human donors from African endemic areas. Parasite Immunol 2002; 24: 141-150.
23. Sedegah M, Charoenvit Y, Minh L et al. Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Therapy 2004; 11: 448-456.
24. Kumar S, Villinger F, Oakley M et al. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor. Immunol Lett 2002; 81: 13-24.
25. Kolodny N, Kitov S, Vassell MA et al. Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli. J Chromatogr B 2001; 762: 77-86.
26. Daubersies P, Thomas AW, Millet P et al. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat Med 2000; 6: 1258-1263.
27. Caspers P, Etlinger H, Matile H, Pink JR, Stuber D, Takacs B. A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1. Mol Biochem Parasitol 1991; 47: 143-150.
28. Charoenvit Y, Mellouk S, Cole C et al. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoeli sporozoites. J Immunol 1991; 146: 1020-1025.
29. Blum Tirouvanziam U, Servis C, Habluetzel A et al. Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. J Immunol 1995; 154: 3922-3931.
30. Wizel B, Rogers WO, Houghten RA, Lanar DE, Tine JA, Hoffman SL. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2. Eur J Immunol 1994; 24: 1487-1495.
31. Miyahira Y, Murata K, Rodriguez D et al. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods 1995; 181: 45-54.
32. Sedegah M, Jones TR, Kaur M et al. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc Natl Acad Sci USA 1998; 95: 7648-7653.